BATON ROUGE, La., Sept. 20 /PRNewswire-FirstCall/ -- Albemarle Corporation (NYSE: ALB - News), a world leader in custom fine chemical manufacturing, has signed an agreement with DSM Pharmaceutical Products (DSM), a business group of Royal DSM NV, to purchase the assets along with the fine chemistry services and pharmachemicals business associated with DSM’s South Haven, Michigan facility.
